Lexaria Bioscience Corp. (LEXX)

0.6684 -0.01 (-0.89%) USD  |  NASDAQ  |  May 07, 10:55
More

Lexaria Bioscience Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Sirona Biochem Corp. --
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. Upgrade